Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0001493152-19-014834

President and CEO gave up 5,343 shares (to pay taxes)

  • President and CEO acquired 15,450 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Culley Brian M President and CEO 2019-09-30 Option exercise +15,450 140,410 D: show line 1 in the form
Culley Brian M President and CEO 2019-09-30 Shares withheld for taxes −5,343 $0.98 $5,236 135,067 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Culley Brian M President and CEO 2019-09-30 Option exercise · Restricted Stock Units −15,450 169,950 D: show line 3 in the form
Loading xslF345X03/ownership.xml…